Challenges in shared decision making in advanced cancer care: a qualitative longitudinal observational and interview study

• Published in: Health expectations : an international journal of public participation in health care and health policy 2017-02, Vol.20 (1), p.69-84
• Main Authors: Brom, Linda, De Snoo‐Trimp, Janine C., Onwuteaka‐Philipsen, Bregje D., Widdershoven, Guy A. M., Stiggelbout, Anne M., Pasman, H. Roeline W.
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aged, 80 and over; Attitude of Health Personnel; Cancer; Cancer patients; Cancer therapies; Care and treatment; Chemotherapy; Clinical decision making; Clinics; Collaboration; Communication; Death & dying; Decision analysis; Decision Making; end of life; Female; Group decision making; Humans; Interviews as Topic; Longitude; Longitudinal Studies; Male; Medical personnel; Medical prognosis; Middle Aged; Neoplasms - drug therapy; Neoplasms - pathology; Oncology, Experimental; Original Research Paper; Original Research Papers; Palliative care; Participation; Patient care planning; Patient Participation; Patient satisfaction; Patients; Physician-Patient Relations; Physicians; Precision medicine; Qualitative Research; Quality of life; Researchers; Risk communication; shared decision making; treatment options
• ISSN: 1369-6513; 1369-7625
• DOI: 10.1111/hex.12434

Background Patients' preferences and expectations should be taken into account in treatment decision making in the last phase of life. Shared decision making (SDM) is regarded as a way to give the patient a central role in decision making. Little is known about how SDM is used in clinical practice in advanced cancer care. Objective To examine whether and how the steps of SDM can be recognized in decision making about second‐ and third‐line chemotherapy. Methods Fourteen advanced cancer patients were followed over time using face‐to‐face in‐depth interviews and observations of the patients' out‐clinic visits. Interviews and outpatient clinic visits in which treatment options were discussed or decisions made were transcribed verbatim and analysed using open coding. Results Patients were satisfied with the decision‐making process, but the steps of SDM were barely seen in daily practice. The creation of awareness about available treatment options by physicians was limited and not discussed in an equal way. Patients' wishes and concerns were not explicitly assessed, which led to different expectations about improved survival from subsequent lines of chemotherapy. Conclusion To reach SDM in daily practice, physicians should create awareness of all treatment options, including forgoing treatment, and communicate the risk of benefit and harm. Open and honest communication is needed in which patients' expectations and concerns are discussed. Through this, the difficult process of decision making in the last phase of life can be facilitated and the focus on the best care for the specific patient is strengthened.